CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-09 | MORSE DANIEL E. Director | Sale | −7,000 | $0.81 | $6K | 7,866 |
| 2018-02-28 | MORSE DANIEL E. Director | Sale | −7,000 | $0.79 | $6K | 14,866 |
| 2018-02-26 | MORSE DANIEL E. Director | Sale | −7,000 | $0.79 | $6K | 21,866 |
| 2018-02-22 | MORSE DANIEL E. Director | Sale | −7,800 | $0.78 | $6K | 28,866 |
Page 15 of 15 · 284 trades